Skip to content Skip to global navigation Skip to main navigation Skip to sub navigation Skip to search
NHMRC

MFR 11 - Strategic Review of Health and Medical Research in Australia

Matter for Review

11. "Ways in which the Commonwealth’s e-health reforms can be leveraged to improve research and translation opportunities, including the availability, linkage and quality of data."

Resources


Clinical Trials Action Group

Clinical Trials Action Group (CTAG) - was formed in October 2009 by the then Senator the Hon Kim Carr, Minister for Innovation, Industry, Science and Research, and the Hon Nicola Roxon, MP, the then Minister for Health and Ageing.

CTAG was established in response to the Pharmaceutical Industry Strategy Group Final Report to identify and progress necessary reforms to secure Australia’s competitiveness in the clinical trials sector.

The CTAG report Clinically Competitive: Boosting the Business of Clinical Trials In Australia was released by Ministers Carr and Roxon on behalf of the Australian Government on 3 March 2011.